Literature DB >> 10767103

The Open Artery Hypothesis: Past, Present, and Future.

M Goel1, J T Dodge, M Rizzo, C McLean, K A Ryan, W L Daley, C P Cannon, C M Gibson.   

Abstract

The survival benefit following a reperfusion strategy, be it pharmacologic or mechanical, appears to be due to both full and early reperfusion. While the TIMI Flow Grade classification scheme has been a useful tool to assess coronary blood flow in acute syndromes, it has several limitations. A newer method of assessing coronary blood flow called the Corrected TIMI Frame Count method has the following advantages: (1) it is a continuous quantitative variable rather than a categorical qualitative variable; (2) the flow in the non-culprit artery is not assumed to be normal as it is in the assessment of TIMI Grade 3 Flow; (3) there is simplified reporting of reperfusion efficacy through the use of a single number instead of expressing the data in 2 to 4 categories; (4) because a single number rather than 4 categories is used to report the data, there is more efficient use of the dataset by increasing the statistical power; and finally (5) coronary flow can be expressed in intuitive terms (e.g. time or cm/sec for strategy A versus time or cm/sec for strategy B). This paper reviews the history of the open artery hypothesis and recent advances in the field.

Year:  1998        PMID: 10767103     DOI: 10.1023/a:1008817810451

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  67 in total

1.  Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-08-05       Impact factor: 91.245

2.  Functional abnormalities in nonoccluded regions of myocardium after experimental coronary occlusion.

Authors:  H L Wyatt; J S Forrester; P L da Luz; G A Diamond; R Chagrasulis; H J Swan
Journal:  Am J Cardiol       Date:  1976-03-04       Impact factor: 2.778

3.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

4.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial.

Authors:  W D Weaver; M Cerqueira; A P Hallstrom; P E Litwin; J S Martin; P J Kudenchuk; M Eisenberg
Journal:  JAMA       Date:  1993-09-08       Impact factor: 56.272

5.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

Authors:  R J Gibbons; D R Holmes; G S Reeder; K R Bailey; M R Hopfenspirger; B J Gersh
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

6.  Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies.

Authors:  A Vogt; R von Essen; U Tebbe; W Feuerer; K F Appel; K L Neuhaus
Journal:  J Am Coll Cardiol       Date:  1993-05       Impact factor: 24.094

7.  New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA.

Authors:  C R Benedict; C J Refino; B A Keyt; R Pakala; N F Paoni; G R Thomas; W F Bennett
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

8.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

Authors:  E J Topol; R M Califf; B S George; D J Kereiakes; C W Abbottsmith; R J Candela; K L Lee; B Pitt; R S Stack; W W O'Neill
Journal:  N Engl J Med       Date:  1987-09-03       Impact factor: 91.245

9.  GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.

Authors: 
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

10.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  1 in total

1.  Usefulness of reperfusion ventricular arrhythmias in non-invasive prediction of early reperfusion and sustained coronary artery patency in acute myocardial infarction.

Authors:  J A Chiladakis; N Vlachos; N Patsouras; A Mazarakis; A S Manolis
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.